Prof. Schwammenthal was born in Israel. Training in Internal Medicine and Cardiology at the University Hospitals of Muenster and Duesseldorf. Research Fellowship at the Massachusetts General Hospital, Harvard Medical School (1992-1994) and cooperation with the Georgia Institute of Technology (in vitro flow models of valvular heart disease). PhD in Cardiovascular Physiology (University of Muenster 1994). Main research interests: pathomechanisms of valvular heart disease, left ventricular function and hemodynamics, cardiovascular imaging. Since 1994 at Sheba Medical Center, Tel Hashomer. Between 2001 and 2003 Director of its Cardiac Outpatient Clinic and until 2012 Director of the Cardiac Rehabilitation Institute at Sheba and Associate Professor of Cardiology at Tel Aviv University. Founder and consulting CTO of Ventor Technologies (2003-2009), acquired in 2009 by Medtronic Inc. Founder and Chief Medical Officer Magenta Medical (since 2012). Part of the founding team of AISAP (AI-powered ultrasound diagnostics at the point of care (since 2021).